title: Activated clotting time monitoring during osteocutaneous free fibula flap surgery.
authors: Department of Surgery, Division of Plastic and Reconstructive Surgery, University of Florida Health System, University of Florida Medical School, Gainesville, Fla.
authors: Nirav
authors: N
authors: Patel
authors: Dhruv
authors: D
authors: Singhal
mesh_terms: D000368:Aged; D000925:Anticoagulants / Q000008:administration & dosage / Q000494:pharmacology*; D001777:Blood Coagulation / Q000187:drug effects*; D002294:Carcinoma, Squamous Cell / Q000150:complications / Q000473:pathology / Q000601:surgery*; D017984:Enoxaparin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D005153:Facial Neoplasms / Q000150:complications / Q000601:surgery*; D005260:Female; D058752:Free Tissue Flaps; D006493:Heparin / Q000008:administration & dosage / Q000494:pharmacology* / Q000627:therapeutic use; D006801:Humans; D007430:Intraoperative Care / Q000379:methods*; D008334:Mandible / Q000473:pathology / Q000601:surgery; D008866:Microsurgery; D064827:Myocutaneous Flap; D009361:Neoplasm Invasiveness; D011183:Postoperative Complications / Q000209:etiology / Q000517:prevention & control; D019651:Plastic Surgery Procedures / Q000379:methods*; D013920:Thrombocythemia, Essential / Q000150:complications; D019851:Thrombophilia / Q000150:complications / Q000188:drug therapy*; D013924:Thrombophlebitis / Q000209:etiology / Q000628:therapy; D016306:Vena Cava Filters; D014914:Whole Blood Coagulation Time
chemical_list: D000925:Anticoagulants; D017984:Enoxaparin; D006493:Heparin
references: Wang TY, Serletti JM, Cuker A, et al. Free tissue transfer in the hypercoagulable patient: A review of 58 flaps. Plast Reconstr Surg. 2012;129:443–453
references: Mabry CD, Thompson BW, Read RC. Activated clotting time (ACT) monitoring of intraoperative heparinization in peripheral vascular surgery. Am J Surg. 1979;138:894–900
references: Palmer K, Ridgway T, Al-Rawi O, Poullis M. Heparin therapy during extracorporeal circulation: Deriving an optimal activated clotting time during cardiopulmonary bypass for isolated coronary artery bypass grafting. J Extra Corpor Technol. 2012;44:145–150